• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Membranes (Basel) . Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces

tetano

Editor, Senior Moderator
Membranes (Basel)


. 2020 Aug 30;10(9):E215.
doi: 10.3390/membranes10090215.
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization


Taha Azad[SUP] 1 2 [/SUP], Ragunath Singaravelu[SUP] 1 2 [/SUP], Mathieu J F Crupi[SUP] 1 2 [/SUP], Taylor Jamieson[SUP] 1 2 [/SUP], Jaahnavi Dave[SUP] 1 2 [/SUP], Emily E F Brown[SUP] 1 2 [/SUP], Reza Rezaei[SUP] 1 2 [/SUP], Zaid Taha[SUP] 1 2 [/SUP], Stephen Boulton[SUP] 1 2 [/SUP], Nikolas T Martin[SUP] 1 2 [/SUP], Abera Surendran[SUP] 1 2 [/SUP], Joanna Poutou[SUP] 1 2 [/SUP], Mina Ghahremani[SUP] 3 [/SUP], Kazem Nouri[SUP] 4 [/SUP], Jack T Whelan[SUP] 1 2 [/SUP], Jessie Duong[SUP] 1 2 [/SUP], Sarah Tucker[SUP] 1 2 [/SUP], Jean-Simon Diallo[SUP] 1 2 [/SUP], John C Bell[SUP] 1 2 [/SUP], Carolina S Ilkow[SUP] 1 2 [/SUP]



Affiliations

Abstract

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic presents an urgent need for an effective vaccine. Molecular characterization of SARS-CoV-2 is critical to the development of effective vaccine and therapeutic strategies. In the present study, we show that the fusion of the SARS-CoV-2 spike protein receptor-binding domain to its transmembrane domain is sufficient to mediate trimerization. Our findings may have implications for vaccine development and therapeutic drug design strategies targeting spike trimerization. As global efforts for developing SARS-CoV-2 vaccines are rapidly underway, we believe this observation is an important consideration for identifying crucial epitopes of SARS-CoV-2.

Keywords: SARS-CoV-2; receptor-binding domain; spike protein; transmembrane domain; trimerization; vaccine development.
 
Back
Top Bottom